New authorisations granted
The European Commission has granted authorisations for:
- Two uses of chromium trioxide by Salzgitter Flachstahl GmbH. The review period expires on 31 December 2032;
- Two uses of (1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO) by LETI Pharma, S.L.U. and to Vetter Pharma-Fertigung GmbH & Co. KG. The review periods for these uses expire on 31 December 2030 and 4 January 2026 respectively.